Maternal serologic testing for thrombophilia at the time of loss and/or in the postpartum period (i.e., protein S is suppressed in pregnancy) is an important part of the evaluation. [4] Therefore ...

Anticoagulants and aspirin are the best studied and most commonly utilized therapeutic agents used to prevent pregnancy complications in thrombophilic women. The use of anticoagulant therapy ...

Fetal loss was reduced from 53 to 15 per cent. Cosgrove and Chesley 8 have placed the fetal loss in all pregnant women with essential hypertension, regardless of severity, at 38 per cent.

Deciding to conceive again following a miscarriage can be a confusing, stressful and painful decision to make. It is normal to have many new questions and concerns, but knowing what to expect can ...